T cells in autoimmunity and allograft rejection

Area of Science:

• Immunology
• Transplantation Immunology
• Molecular Medicine

Background:

• T lymphocytes are crucial for immune responses and implicated in immune-mediated diseases.
• Understanding T lymphocyte activation and differentiation is key for developing new immunotherapies.
• Targeting HLA-peptide interactions, T cell receptor (TCR) signaling, and effector molecules offers potential therapeutic strategies.

Purpose of the Study:

• To investigate the effects of synthetic peptides derived from HLA class I molecules on T lymphocyte function.
• To explore the potential of these peptides as novel immunosuppressive agents.

Main Methods:

• Synthesizing peptides corresponding to linear sequences of HLA class I molecules.
• Assessing the inhibitory effects of these peptides on cytotoxic T lymphocytes (CTLs).
• Evaluating the impact of specific HLA class I peptides on rat heterotopic heart transplant survival in combination with cyclosporin A.

Main Results:

• Peptides from conserved regions of HLA class I molecules significantly inhibited CTL activity.
• Peptides from a specific conserved region of the HLA class I alpha 1 alpha helix prolonged rat heart transplant survival.
• The combination therapy with peptides and sub-therapeutic cyclosporin A demonstrated enhanced immunosuppression.

Conclusions:

• Soluble HLA molecules may function as natural immunoregulatory factors in vivo.
• Synthetic peptides targeting HLA class I molecules show promise as novel immunosuppressive drugs.
• These findings support the development of peptide-based therapies for immune-mediated diseases and transplant rejection.